Ci et al. [14] found that a knockdown of KYNU expression could inhibit the proliferation of cutaneous squamous cell carcinoma by inhibiting the PI3K/AKT signaling pathway. This evidence concerns the gene AKT1 and cutaneous squamous cell carcinoma.